MIG Capital

MIG Capital stands as a premier German venture capital firm specializing in early-stage investments. Since its establishment in 2004, the firm has deployed over €750 million across approximately 55 innovative companies throughout Europe, focusing primarily on Life Science and Deep Tech sectors. With a current portfolio of 33 groundbreaking enterprises, MIG Capital has established itself as a transformative force in the European venture ecosystem, converting visionary ideas into tangible market value through strategic financial backing and operational support.

The investment approach at MIG Capital centers on identifying disruptive technologies and scientific breakthroughs with significant commercial potential. Their Life Science investments span biotechnology, pharmaceuticals, medical devices, and digital health solutions, while their Deep Tech portfolio encompasses advanced materials, quantum computing, artificial intelligence, and other frontier technologies. This dual focus allows MIG to capitalize on innovations at the intersection of multiple disciplines, where some of the most promising market opportunities often emerge.

Beyond mere financial investment, MIG Capital provides portfolio companies with comprehensive support throughout their growth journey. Their team combines scientific expertise with business acumen, offering guidance on strategic development, market entry strategies, intellectual property management, and subsequent funding rounds. This hands-on approach has enabled numerous portfolio companies to achieve significant milestones, including successful exits through acquisitions and IPOs, cementing MIG's reputation for value creation in the European innovation landscape.

As the European tech ecosystem continues to mature, MIG Capital remains committed to fostering the next generation of breakthrough companies. Their investment strategy typically targets pre-seed to Series B rounds, with the flexibility to participate in follow-on investments for high-performing portfolio companies. With a strong track record spanning nearly two decades, MIG has developed an extensive network of industry partners, research institutions, and co-investors across Europe, positioning them to identify promising opportunities early and support transformative innovation that addresses significant global challenges in healthcare, sustainability, and digital transformation.